<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:art="http://www.rsc.org/schema/rscart38" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rsc="urn:rsc.org" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-56FZ7G');</script><!--End Google Tag Manager--><title>Fabrication of red blood cell membrane-camouflaged Cu 2−x Se nanoparticles for phototherapy in the second near-infrared window   - Chemical Communications (RSC Publishing) DOI:10.1039/C9CC03148K</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2019/cc/c9cc03148k"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":0,"applicationTime":219,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(31),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(32),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),S=t(15),P=t(10),M=t("ee"),C=M.get("tracer"),N=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),P.on(p,r),M.on(d,o),b.on(l,o),P.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),S.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,N(!0)),w[v]("load",i,N(!0)),w[v]("popstate",function(){i(0,U>1)},N(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(32),a=t(31);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(31),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(28),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);return e.protocol&&"data"===e.protocol?void g("Ajax/DataUrl/Excluded"):void(e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this)))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=t(25).recordSupportability,y=NREUM.o.REQ,x=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof x&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;if("string"==typeof i?n=i:"object"==typeof i&&i instanceof y?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n),"data"!==this.params.protocol){var s=(""+(i&&i instanceof y&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}}),u.on("fetch-done",function(t,e){if(this.endTime=a.now(),this.params||(this.params={}),"data"===this.params.protocol)return void g("Ajax/DataUrl/Excluded");this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];if(0===(t||"").indexOf("data:"))return{protocol:"data"};var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(31),s=t(32),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(33);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?l("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&l("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(f&&f<r.startTime)return;var o=[r],i=a({});i&&o.push(i),l("lcp",o)}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||l("cls",[t])})}function a(t){var e=navigator.connection||navigator.mozConnection||navigator.webkitConnection;if(e)return e.type&&(t["net-type"]=e.type),e.effectiveType&&(t["net-etype"]=e.effectiveType),e.rtt&&(t["net-rtt"]=e.rtt),e.downlink&&(t["net-dlink"]=e.downlink),t}function s(t){if(t instanceof w&&!y){var e=Math.round(t.timeStamp),n={type:t.type};a(n),e<=h.now()?n.fid=h.now()-e:e>h.offset&&e<=Date.now()?(e-=h.offset,n.fid=h.now()-e):e=h.now(),y=!0,l("timing",["fi",e,n])}}function c(t){"hidden"===t&&(f=h.now(),l("pageHide",[f]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var f,u,d,p,l=t("handle"),h=t("loader"),m=t(30),v=t(23),w=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){u=new PerformanceObserver(r);try{u.observe({entryTypes:["paint"]})}catch(g){}d=new PerformanceObserver(o);try{d.observe({entryTypes:["largest-contentful-paint"]})}catch(g){}p=new PerformanceObserver(i);try{p.observe({type:"layout-shift",buffered:!0})}catch(g){}}if("addEventListener"in document){var y=!1,x=["click","keydown","mousedown","pointerdown","touchstart"];x.forEach(function(t){document.addEventListener(t,s,v(!1))})}m(c)}},{}],28:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(t)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],29:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],30:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],31:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],32:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],33:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(31),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!T++){var t=O.info=NREUM.info,e=m.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(E,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+O.offset],null,"api"),s("timing",["load",n]);var r=m.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=l+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===m.readyState&&i()}function i(){s("mark",["domContent",a()+O.offset],null,"api")}var a=t(26),s=t("handle"),c=t(31),f=t("ee"),u=t(29),d=t(21),p=t(23),l=d.getConfiguration("ssl")===!1?"http":"https",h=window,m=h.document,v="addEventListener",w="attachEvent",g=h.XMLHttpRequest,y=g&&g.prototype,x=!1;NREUM.o={ST:setTimeout,SI:h.setImmediate,CT:clearTimeout,XHR:g,REQ:h.Request,EV:h.Event,PR:h.Promise,MO:h.MutationObserver};var b=""+location,E={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1216.min.js"},R=g&&y&&y[v]&&!/CriOS/.test(navigator.userAgent),O=e.exports={offset:a.getLastTimestamp(),now:a,origin:b,features:{},xhrWrappable:R,userAgent:u,disabled:x};if(!x){t(20),t(27),m[v]?(m[v]("DOMContentLoaded",i,p(!1)),h[v]("load",r,p(!1))):(m[w]("onreadystatechange",o),h[w]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var T=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(32),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Zhou Liu"/><meta name="DC.Creator" content="Jinquan Wang"/><meta name="DC.Creator" content="Kangqiang Qiu"/><meta name="DC.Creator" content="Xinxing Liao"/><meta name="DC.Creator" content="Thomas W. Rees"/><meta name="DC.Creator" content="Liangnian Ji"/><meta name="DC.Creator" content="Hui Chao"/><meta name="DC.title" content="Fabrication of red blood cell membrane-camouflaged Cu 2−x Se nanoparticles for phototherapy in the second near-infrared window  "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2019/06/04"/><meta name="DC.Identifier" scheme="doi" content="10.1039/C9CC03148K"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Fabrication of red blood cell membrane-camouflaged Cu 2−x Se nanoparticles for phototherapy in the second near-infrared window  "/><meta name="citation_author" content="Zhou Liu"/><meta name="citation_author" content="Jinquan Wang"/><meta name="citation_author" content="Kangqiang Qiu"/><meta name="citation_author" content="Xinxing Liao"/><meta name="citation_author" content="Thomas W. Rees"/><meta name="citation_author" content="Liangnian Ji"/><meta name="citation_author" content="Hui Chao"/><meta name="citation_online_date" content="2019/05/13"/><meta name="citation_date" content="2019"/><meta name="citation_journal_title" content="Chemical Communications"/><meta name="citation_volume" content="55"/><meta name="citation_issue" content="46"/><meta name="citation_firstpage" content="6523"/><meta name="citation_lastpage" content="6526"/><meta name="citation_doi" content="10.1039/C9CC03148K"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2019/cc/c9cc03148k"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2019/cc/c9cc03148k"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2019/cc/c9cc03148k"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-56FZ7G" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2019/cc/c9cc03148k">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:c9cc02637a)" href="/en/content/articlehtml/2019/cc/c9cc02637a" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:c9cc02405k)" href="/en/content/articlehtml/2019/cc/c9cc02405k" target="_BLANK">Next Article</a></span></div><div class="right_head"><div id="crossmark_container"><div id="crossmark-content"><a id="open-crossmark" href="#" data-target="crossmark"><img style="max-width:100px" id="crossmark-logo" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg" alt="Check for updates"/></a><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"> </script></div></div> </div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/C9CC03148K">10.1039/C9CC03148K</a>
(Communication)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/1364-548X/1996">Chem. Commun.</a></span>, 2019, <strong>55</strong>, 6523-6526</div><h1 id="sect212"><span class="title_heading">Fabrication of red blood cell membrane-camouflaged Cu<small><sub>2−<span class="italic">x</span></sub></small>Se nanoparticles for phototherapy in the second near-infrared window<a title="Select to navigate to footnote" href="#fn1">†</a></span></h1><p class="header_text">
      <span class="bold">
        
          
            Zhou 
            Liu
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Jinquan 
            Wang
          
        
      </span><sup><span class="sup_ref italic">b</span></sup>, 
      <span class="bold">
        
          
            Kangqiang 
            Qiu
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Xinxing 
            Liao
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Thomas W. 
            Rees
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Liangnian 
            Ji
          
        
      </span><sup><span class="sup_ref italic">a</span></sup><span class="bold"> and </span>
      <span class="bold">
        
          
            Hui 
            Chao
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Hui Chao (orcid.org/0000-0003-4153-5303) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0003-4153-5303"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*<sup><span class="sup_ref italic">ac</span></sup>
      <br/><a id="affa"><sup><span class="sup_ref italic">a</span></sup></a><span class="italic">MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, Sun Yat-Sen University, Guangzhou 510275, P. R. China. E-mail: <a href="mailto:ceschh@mail.sysu.edu.cn">ceschh@mail.sysu.edu.cn</a></span>
      <br/><a id="affb"><sup><span class="sup_ref italic">b</span></sup></a><span class="italic">Guangdong Provincial Key Laboratory of Biotechnology Candidate Drug Research, Guangdong Pharmaceutical University, Guangzhou, 510006, China</span>
      <br/><a id="affc"><sup><span class="sup_ref italic">c</span></sup></a><span class="italic">MOE Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, 400201, P. R. China</span>
    </p><div id="art-admin"><span class="italic bold">Received 
      23rd April 2019
    </span><span class="bold italic">, Accepted 13th May 2019</span></div><p class="bold italic">First published on 13th May 2019</p><hr/><div class="abstract"><h2>Abstract</h2><p>Cu<small><sub>2−<span class="italic">x</span></sub></small>Se nanoparticles (Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs) were camouflaged with a red blood cell membrane (RBC) to create nanoparticles with improved biocompatibility, longer blood retention times, excellent absorption properties, superior photothermal conversion efficiency (67.2%) and singlet oxygen production capabilities for the synergistic photothermal and photodynamic therapy of cancer in the second near-infrared (NIR-II) window.</p></div><hr/>
    
      <span>Phototherapy (which includes photothermal therapy (PTT) and photodynamic therapy (PDT)) is considered one of the most promising therapeutic modalities for cancer treatment owing to unique characteristics such as high selectivity, non-invasiveness, and low toxicity when compared to traditional radiotherapy and chemotherapy.<a title="Select to navigate to reference" href="#cit1"><sup><span class="sup_ref">1,2</span></sup></a> In PTT cancer cell death is induced by photothermal agents which are excited by light to generate hyperthermia,<a title="Select to navigate to references" href="#cit3"><sup><span class="sup_ref">3</span></sup></a> while PDT employs photosensitizers to produce cytotoxic reactive oxygen species (ROS).<a title="Select to navigate to references" href="#cit4"><sup><span class="sup_ref">4</span></sup></a> Although PTT is effective for tumor ablation, uneven heat delivery in tumor sites can lead to tumor regrowth/reoccurrence.<a title="Select to navigate to references" href="#cit5"><sup><span class="sup_ref">5</span></sup></a> For PDT, the tissue penetration depth of the light used for excitation can cause considerable restrictions.<a title="Select to navigate to references" href="#cit6"><sup><span class="sup_ref">6</span></sup></a> In order to address the shortcomings of PTT and PDT, a combined photothermal agent and photosensitizer was developed. The majority of research reported thus far on phototherapy focuses on the first NIR (NIR-I) window (750–950 nm). Compared to the well-explored NIR-I window, the NIR-II window (1000–1350 nm) has the advantages of larger maximum permissible exposure (MPE, 1 W cm<small><sup>−2</sup></small>, American National Standard for Safe Use of Lasers, ANSI Z136.1-2007) and deeper tissue penetration.<a title="Select to navigate to reference" href="#cit7"><sup><span class="sup_ref">7–10</span></sup></a> Considering the advantages of both PDT and PTT as well as the benefits of agents which are activated in the NIR-II window, there has been a recent increase in interest in the fabrication of dual-functional agents for the simultaneous generation of heat and ROS under NIR-II light irradiation.</span>
      <p class="otherpara">Based on the optimal photo-induced properties of PTT and PDT in cancer therapy, a reasonable combination of PTT and PDT is expected to produce synergistic therapeutic effects.<a title="Select to navigate to reference" href="#cit11"><sup><span class="sup_ref">11,12</span></sup></a> Some materials, including Cu<small><sub>2</sub></small>(OH)PO<small><sub>4</sub></small>@PAA,<a title="Select to navigate to references" href="#cit13"><sup><span class="sup_ref">13</span></sup></a> TeO<small><sub>2</sub></small>/(NH<small><sub>4</sub></small>)<small><sub><span class="italic">x</span></sub></small>WO<small><sub>3</sub></small> nanoribbons,<a title="Select to navigate to references" href="#cit14"><sup><span class="sup_ref">14</span></sup></a> Cs<small><sub><span class="italic">x</span></sub></small>WO<small><sub>3</sub></small> nanorods,<a title="Select to navigate to references" href="#cit15"><sup><span class="sup_ref">15</span></sup></a> have been used as dual-functional agents for synergetic phototherapy by 1064 nm laser and exhibit some anti-cancer effects. However, the <span class="italic">in vivo</span> applications of dual functional materials still faces many challenges, including low photothermal conversion efficiency, poor biocompatibility, and short circulation times. Recently, the biomimetic approach of nanomaterials camouflaged by natural cell membranes, has attracted particular attention due to the advantages of long circulation times, biodegradability, non-immunogenicity, and biocompatibility.<a title="Select to navigate to references" href="#cit16"><sup><span class="sup_ref">16</span></sup></a> As a most abundant and affordable biological carrier among the cell membranes, red blood cell (RBC) membrane has been used as biomimetic coating on nanomaterials with various functions.<a title="Select to navigate to reference" href="#cit17"><sup><span class="sup_ref">17,18</span></sup></a></p>
      <p class="otherpara">In this work, to improve the therapeutic efficiency of synergetic phototherapy in the NIR-II window, RBC membrane was used to camouflage a NIR-II absorptive Cu<small><sub>2−<span class="italic">x</span></sub></small>Se nanoparticle (RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs), which has been well-developed for phototherapy in the NIR-I window<a title="Select to navigate to references" href="#cit19"><sup><span class="sup_ref">19</span></sup></a> but has not been explored for synergetic phototherapy in the NIR-II window. Specifically, the photothermal conversion efficiency (67.2%) of Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs in the NIR-II window is higher than in the NIR-I window and higher than most previous reports such as semiconducting copolymer nanoparticles (43.4%),<a title="Select to navigate to references" href="#cit20"><sup><span class="sup_ref">20</span></sup></a> Au@Cu<small><sub>2−<span class="italic">x</span></sub></small>S core–shell nanocrystals (43.2%),<a title="Select to navigate to references" href="#cit21"><sup><span class="sup_ref">21</span></sup></a> 2D niobium carbide (45.65%),<a title="Select to navigate to references" href="#cit22"><sup><span class="sup_ref">22</span></sup></a> and Cu<small><sub>3</sub></small>BiS<small><sub>3</sub></small> nanorods (40.7%).<a title="Select to navigate to references" href="#cit23"><sup><span class="sup_ref">23</span></sup></a> The dual-function of heat and ROS production of the RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs was investigated under 1064 nm laser irradiation. The advantages given by the RBC membrane to the Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs were demonstrated. Systematic evaluation was conducted <span class="italic">in vitro</span> and <span class="italic">in vivo</span> to confirm the high efficacy of the RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs as synergetic phototherapeutic agents for the treatment of cancer.</p>
      <p class="otherpara">Schematic illustration of the synthesis of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs and their use in phototherapy is shown in <a title="Select to navigate to scheme" href="#imgsch1">Scheme 1</a>. In the design of nanoparticles for biological applications, surface chemistry is an essential factor. Transmission electron microscopy (TEM) gave an average size of 53.0 ± 3.1 for Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs while dynamic light scattering (DLS) measurement gave an average size of 75.0 nm (Fig. S1A and B, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). After coating with RBC, the obtained RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs displayed a well-dispersed distribution. However, the size of the RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs was increased. The diameter measured by DLS was 161.2 nm, and the average diameter obtained by TEM was 152.5 ± 5.2 nm (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1A</a> and Fig. S1C, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). This indicates that several nanoparticles are packed into the red cell membrane under the physical pressure. The surface zeta potential of the Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs was −13.1 mV, while after fusing with the RBC, the surface zeta potential increased to −24.8 mV (Fig. S2A, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). Next their stability in aqueous solution and DMEM (added 10% FBS) was assessed, the change in size confirmed that the RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs were stable after five days storage, without obvious co-aggregation (Fig. S2B, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>).</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch1"><a href="/image/article/2019/CC/c9cc03148k/c9cc03148k-s1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9cc03148k-s1.tif" src="/image/article/2019/CC/c9cc03148k/c9cc03148k-s1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 1 </b> <span id="sch1"><span class="graphic_title">Illustration of the synthesis and the phototherapy of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><a href="/image/article/2019/CC/c9cc03148k/c9cc03148k-f1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9cc03148k-f1.tif" src="/image/article/2019/CC/c9cc03148k/c9cc03148k-f1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title">(A) TEM image of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs. (B) Absorbance spectra of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs and Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs. (C) The heat transfer from the cooling period. (D) ESR spectra of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs before and after 1064 nm laser irradiation in 5 min.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">To evaluate the photothermal performance of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs, the absorption spectrum of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs was measured revealing strong absorption in the near infrared region, indicating that the RBC membrane coating process had made little change to the absorption properties compared to bare Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1B</a> and Fig. S2C, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). The temperature change of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs exposed to 1064 nm NIR laser irradiation with the power of 0.8 W cm<small><sup>−2</sup></small> at varying concentrations were recorded (Fig. S3A and B, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). A rapid temperature increase was observed from 25.0 to 62.3 °C over 5 min with a Cu<small><sub>2−<span class="italic">x</span></sub></small>Se concentration of 40 μg mL<small><sup>−1</sup></small>. RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs were then exposed to 1064 nm laser at various powers (0.8, 0.9 and 1.0 W cm<small><sup>−2</sup></small>) to evaluate the photothermal performance in comparison to pure water. RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs were shown to rapidly convert NIR light into thermal energy (Fig. S3C, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>).</p>
      <p class="otherpara">In order to investigate the photothermal stability of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs, the temperature variation recycle curves of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs were measured. The photothermal performance of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs showed no apparent deterioration during the recycling (Fig. S3D, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). Next, according to the reported formula,<a title="Select to navigate to references" href="#cit19"><sup><span class="sup_ref">19</span></sup></a> the photothermal-conversion efficiency (η) of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs was calculated on the basis of the value of the time constant for heat transfer and the maximum steady-state temperature (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1C</a> and Fig. S3E, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>), which was 67.2% for 1064 nm, obviously higher than other nanomaterials at NIR-II laser irradiation.</p>
      <p class="otherpara">The photothermal properties of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs were compared in both the NIR-I and NIR-II windows, the temperature of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs irradiated at 1064 nm was significantly higher than those irradiated at 808 nm at all powers tested. The temperature change measured at various tissue depths under NIR-I and NIR-II laser irradiation revealed that, the photothermal and tissue penetration capabilities of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs irradiated at 1064 nm were superior to those measured under 808 nm irradiation (Fig. S3F and S4, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>).</p>
      <p class="otherpara">ROS generation is usually a primary cause of cell death in effective PDT.<a title="Select to navigate to references" href="#cit24"><sup><span class="sup_ref">24</span></sup></a> The ROS generation of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs was measured using 1,3-diphenylisobenzofuran (DPBF) as a sensor to analyse <small><sup>1</sup></small>O<small><sub>2</sub></small> production under 1064 nm laser irradiation over time. As shown in Fig. S5 (ESI<a title="Select to navigate to footnote" href="#fn1">†</a>), with the extension of the irradiation time, the absorbance intensity of DPBF was decreased significantly, showing that DPBF was oxidized by the generated <small><sup>1</sup></small>O<small><sub>2</sub></small>. To further verify the ROS generated by the RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs, the electron spin resonance (ESR) spectrum were applied to analyse the ROS generated under 1064 nm laser irradiation in 5 min (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1D</a>). 2,2,6,6-Tetramethylpiperidine (TEMP) is a typical spin trapping agent for detecting <small><sup>1</sup></small>O<small><sub>2</sub></small>.</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig2"><a href="/image/article/2019/CC/c9cc03148k/c9cc03148k-f2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9cc03148k-f2.tif" src="/image/article/2019/CC/c9cc03148k/c9cc03148k-f2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 2 </b> <span id="fig2"><span class="graphic_title">(A) Cell viability of HepG2 cells treated with or without 1064 nm laser irradiation at different concentrations of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs (5 min, 0.8 W cm<small><sup>−2</sup></small>). (B) The production of ROS in cells incubated with: (i) RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs, (ii) RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs with 1064 nm laser irradiation. (C) The images of HepG2 cells co-incubated with calcein AM (green) and PI (red) (Scale bars = 200 μm).</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">Compared with a control, the results clearly show the typical signal peak of <small><sup>1</sup></small>O<small><sub>2</sub></small> and a higher signal intensity was obtained from RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs <span class="italic">vs.</span> the control.</p>
      <p class="otherpara">The cellular uptake of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs by HepG2 over 24 h is shown in Fig. S6A and B (ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). The uptake increases with time. Moreover, according to previous reports,<a title="Select to navigate to references" href="#cit25"><sup><span class="sup_ref">25</span></sup></a> coating by RBC could be used to avoid immune clearance of the nanoparticles by reducing the uptake by macrophages. So we co-treated RAW264.7 cells with Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs and RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs for 6 h. These results further confirm that uncoated Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs display higher uptake than RBC coated Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs. These results indicate that RBC can effectively reduce macrophage uptake. The distribution of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs was investigated in HepG2 cells (Fig. S7, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). Bio-TEM results reveal the efficient internalization of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs by HepG2 cells in a time-dependent manner (at 6 and 12 h) and that the nanoparticles mainly locate in the lysosomes of the cells.</p>
      <p class="otherpara">Based on these results, the anticancer properties of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs <span class="italic">in vitro</span> were further evaluated. The cytotoxicity was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2A</a>). No obvious toxicity of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs was observed, which demonstrates their excellent biocompatibility due to the addition of RBC. In order to clarify the mechanism of the 1064 nm laser irradiation induced cytotoxicity, a low temperature (4 °C) phototoxic experiment to measure the PDT properties independent of the PTT properties was performed. The PTT properties were also assessed independent of PDT effects by using Vitamin C (VC) as a ROS scavenger. The experiments to test the separate effects of PTT and PDT, were performed at a concentration of 60 μg mL<small><sup>−1</sup></small>. The PDT induced cytotoxicity was found to be 50.0% while the cancer cell inhibition rate induced by PTT was found to be 64.6%. In contrast the combined PTT/PDT cancer cell inhibition rate was much higher at 88%. Additionally, the real-time thermographs after 5 min at different concentrations were measured in Fig. S8 (ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). The generation of ROS in the cellular environment was further confirmed by the intracellular ROS probe 2,7-dichlorofluorescin diacetate (DCFH-DA), which when oxidized by ROS displays green emission (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2B</a>). In the control group, negligible green fluorescence was observed, while cells incubated with RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs green emission could be clearly seen, which shows that RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs can induce the production of ROS under 1064 nm laser irradiation. These results indicate that the combination of PTT and PDT markedly enhances anticancer efficacy, with PTT playing a predominant role. Live/dead cell assay was performed with calcein-AM and PI co-staining, to further confirm the results of the MTT experiments (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2C</a>).</p>
      <p class="otherpara">A hemolysis assay is normally used to assess the cytotoxic effect of nanoparticles,<a title="Select to navigate to references" href="#cit26"><sup><span class="sup_ref">26</span></sup></a> as shown in Fig. S9A (ESI<a title="Select to navigate to footnote" href="#fn1">†</a>), bare Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs caused higher hemolytic activity than RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs, which is in agreement with the corresponding photographs of the erythrocytes (Fig. S9B, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). These results demonstrate that encapsulation by RBC not only gave the RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs enhanced stability but also reduced their hemolytic properties.</p>
      <p class="otherpara">Encouraged by the nanoparticles excellent therapeutic effects <span class="italic">in vitro</span>, further phototherapy experiments were performed <span class="italic">in vivo</span> on HepG2 tumor-bearing mice. After intravenous (IV) administration of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs and Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs (6.6 mg kg<small><sup>−1</sup></small>), the tumor-bearing mice were exposed to 1064 nm NIR laser with a power density of 1.0 W cm<small><sup>−2</sup></small>, and the temperatures of the tumor location measured after 5 min irradiation. Rapid increase to 48 °C was observed with RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs which was higher than for Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs (43.7 °C). This may be due to the higher tumoral accumulation of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs (Fig. S10A and B, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>).</p>
      <p class="otherpara">In order to compare the tumor-accumulation capacities of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs and Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs, their blood circulation and bio-distribution were investigated in the mice. The pharmacokinetic parameters suggested that the blood circulation half-time of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs was 2.14 h, which was 4.43 times to that of Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs after intravenous administration (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3A</a>). After 24 h both of them mainly accumulated in the liver, lungs and spleen. However, compared with free Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs, RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs not only displayed increased tumoral accumulation, but also reduced uptake in the main organs (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3B</a>). These excellent results are due to the prolonged blood circulation of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs compared to Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs.</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig3"><a href="/image/article/2019/CC/c9cc03148k/c9cc03148k-f3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c9cc03148k-f3.tif" src="/image/article/2019/CC/c9cc03148k/c9cc03148k-f3.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 3 </b> <span id="fig3"><span class="graphic_title">(A) The plasma concentration–time curves of Cu concentration after intravenous administration of Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs and RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs. (B) The concentrations of Cu in organs and tumors at 24 h after intravenously administrating Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs and RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs. *<span class="italic">P</span> &lt; 0.05, **<span class="italic">P</span> &lt; 0.01. (C) Photographs of HepG2 tumor-bearing mice and their tumor regions 20 days. (D) Relative volume curves of time-dependent tumor growth. (i) PBS, (ii) PBS + laser, (iii) Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs, (iv) RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs, (v) Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs + laser, (vi) RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs + laser.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">To further assess the tumor inhibitory effect of the nanoparticles (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3C and D</a>), the tumor volumes of mice were measured over 20 days. Those in the treated with nanoparticles and irradiated with 1064 nm laser showed significant decrease in tumor volume after 20 days treatment. The best result was observed for the RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs + laser group. In contrast the tumors on the mice in the four control groups all grew rapidly. There were no obvious changes of the body weight in the tumor-bearing mice (Fig. S10C, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>), indicating the low biotoxicity and side effects of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs for phototherapy <span class="italic">in vivo</span>.</p>
      <p class="otherpara">Hematoxylin–eosin (H&amp;E) was used to stain the tumor sections to further display the synergistic PTT/PDT effect (Fig. S10D and S11, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). The tumors of mice the four control groups displayed normal growth. In contrast there was more nucleus karyopyknosis, karyorrhexis, and karyolysis observed in the two groups treated with nanoparticles and irradiated. The results confirm the phototherapeutic properties of RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs on tumor proliferation.</p>
      <p class="otherpara">In summary, novel RBC coated Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs with high photothermal conversion efficiency and the ability to produce singlet oxygen in the NIR II window were synthesized by a simple method for combined PTT/PDT cancer treatment. The RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs exhibited strong and broad absorbance in the NIR II window. Compared to most previously reported nanoparticles working in the NIR-II window, the RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs showed an excellent PTT efficiency and a higher photothermal conversion efficiency (up to 67.2%) in the NIR-II window. Moreover, due to the RBC camouflage, the RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs displayed significantly prolonged circulation lifetime and improve tumor accumulation. It is important to note that RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs showed enhanced PTT/PDT effects <span class="italic">in vitro</span> and <span class="italic">in vivo</span>. These unique RBC@Cu<small><sub>2−<span class="italic">x</span></sub></small>SeNPs with excellent biocompatibility and highly effective phototherapeutic properties are highly promising for future biomedical applications.</p>
      <p class="otherpara">This work was supported by the National Science Foundation of China (No. 21525105 and 21778079), the 973 Program (No. 2015CB856301), the Ministry of Education of China (No. IRT-17R111), and the Fundamental Research Funds for the Central Universities (No. 17lgjc11).</p>
    
    
      <h2 id="sect579"><span class="a_heading">Conflicts of interest</span></h2>
      <span>There are no conflicts to declare.</span>
    
  
    <span id="sect583"><h2 id="sect582"><span class="a_heading">Notes and references</span></h2></span><ol type="1">
      <li><span id="cit1">M. Karimi, P. Sahandi Zangabad, S. Baghaee-Ravari, M. Ghazadeh, H. Mirshekari and M. R. Hamblin, <span class="italic">J. Am. Chem. Soc.</span>, 2017, <span class="bold">139</span>, 4584–4610 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.6b08313" title="DOI Link to resource 10.1021/jacs.6b08313">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXisFyksr0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28192672%5Buid%5D" title="PubMed Link to resource 28192672">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/1_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit2">Y. Cao, X. Meng, D. Wang, K. Zhang, W. Dai, H. Dong and X. Zhang, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2018, <span class="bold">10</span>, 17732–17741 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.8b05050" title="DOI Link to resource 10.1021/acsami.8b05050">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXptVCit7o%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29737836%5Buid%5D" title="PubMed Link to resource 29737836">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/2_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit3">F. Chen, D. Yang, H. Shen, M. Deng, Y. Zhang, G. Zhong, Y. Hu, L. Weng, Z. Luo and L. Wang, <span class="italic">Chem. Commun.</span>, 2019, <span class="bold">55</span>, 2789–2792 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C8CC09733J&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C8CC09733J">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/3_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit4">Q. Pei, X. Hu, X. Zheng, S. Liu, Y. Li, X. Jing and Z. Xie, <span class="italic">ACS Nano</span>, 2018, <span class="bold">12</span>, 1630–1641 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.7b08219" title="DOI Link to resource 10.1021/acsnano.7b08219">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXht1Gnt78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29346736%5Buid%5D" title="PubMed Link to resource 29346736">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/4_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit5">F. Yan, W. Duan, Y. Li, H. Wu, Y. Zhou, M. Pan, H. Liu, X. Liu and H. Zheng, <span class="italic">Theranostics</span>, 2016, <span class="bold">6</span>, 2337–2351 <a target="_blank" class="DOILink" href="https://doi.org/10.7150/thno.14937" title="DOI Link to resource 10.7150/thno.14937">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhvFyqurrP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27877239%5Buid%5D" title="PubMed Link to resource 27877239">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/5_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit6">W. Fan, P. Huang and X. Chen, <span class="italic">Chem. Soc. Rev.</span>, 2016, <span class="bold">45</span>, 6488–6519 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C6CS00616G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C6CS00616G">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/6_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit7">S.-m. Park, A. Aalipour, O. Vermesh, J. H. Yu and S. S. Gambhir, <span class="italic">Nat. Rev. Mater.</span>, 2017, <span class="bold">2</span>, 17014 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/natrevmats.2017.14" title="DOI Link to resource 10.1038/natrevmats.2017.14">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXntFWmsr0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29876137%5Buid%5D" title="PubMed Link to resource 29876137">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/7_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit8">Z. Wei, M. Wu, S. Lan, J. Li, X. Zhang, D. Zhang, X. Liu and J. Liu, <span class="italic">Chem. Commun.</span>, 2018, <span class="bold">54</span>, 13599–13602 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C8CC07583B&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C8CC07583B">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/8_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit9">A. N. Bashkatov, E. A. Genina, V. I. Kochubey and V. V. Tuchin, <span class="italic">J. Phys. D: Appl. Phys.</span>, 2005, <span class="bold">38</span>, 2543–2555 <a target="_blank" class="DOILink" href="https://doi.org/10.1088/0022-3727/38/15/004" title="DOI Link to resource 10.1088/0022-3727/38/15/004">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXovFSitbs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/9_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit10">M.-F. Tsai, S.-H. G. Chang, F.-Y. Cheng, V. Shanmugam, Y.-S. Cheng, C.-H. Su and C.-S. Yeh, <span class="italic">ACS Nano</span>, 2013, <span class="bold">7</span>, 5330–5342 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nn401187c" title="DOI Link to resource 10.1021/nn401187c">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXntFWnsbw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23651267%5Buid%5D" title="PubMed Link to resource 23651267">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/10_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit11">R. Xing, K. Liu, T. Jiao, N. Zhang, K. Ma, R. Zhang, Q. Zou, G. Ma and X. Yan, <span class="italic">Adv. Mater.</span>, 2016, <span class="bold">28</span>, 3669–3676 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201600284" title="DOI Link to resource 10.1002/adma.201600284">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xks1eltLs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26991248%5Buid%5D" title="PubMed Link to resource 26991248">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/11_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit12">L. Zhang, D. Wang, K. Yang, D. Sheng, B. Tan, Z. Wang, H. Ran, H. Yi, Y. Zhong and H. Lin, <span class="italic">Adv. Sci.</span>, 2018, <span class="bold">5</span>, 1800049 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/advs.201800049" title="DOI Link to resource 10.1002/advs.201800049">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30128231%5Buid%5D" title="PubMed Link to resource 30128231">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/12_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit13">W. Guo, Z. Qiu, C. Guo, D. Ding, T. Li, F. Wang, J. Sun, N. Zheng and S. Liu, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2017, <span class="bold">9</span>, 9348–9358 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.6b15703" title="DOI Link to resource 10.1021/acsami.6b15703">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXjsFCmt7k%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28248076%5Buid%5D" title="PubMed Link to resource 28248076">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/13_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit14">Y. Cheng, F. Yang, G. Xiang, K. Zhang, Y. Cao, D. Wang, H. Dong and X. Zhang, <span class="italic">Nano Lett.</span>, 2019, <span class="bold">19</span>, 1179–1189 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.nanolett.8b04618" title="DOI Link to resource 10.1021/acs.nanolett.8b04618">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30640481%5Buid%5D" title="PubMed Link to resource 30640481">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/14_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit15">W. Guo, C. Guo, N. Zheng, T. Sun and S. Liu, <span class="italic">Adv. Mater.</span>, 2017, <span class="bold">29</span>, 1604157 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201604157" title="DOI Link to resource 10.1002/adma.201604157">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27874227%5Buid%5D" title="PubMed Link to resource 27874227">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/15_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit16">R. H. Fang, A. V. Kroll, W. Gao and L. Zhang, <span class="italic">Adv. Mater.</span>, 2018, <span class="bold">30</span>, 1706759 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201706759" title="DOI Link to resource 10.1002/adma.201706759">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29582476%5Buid%5D" title="PubMed Link to resource 29582476">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/16_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit17">Y. Zhai, W. Ran, J. Su, T. Lang, J. Meng, G. Wang, P. Zhang and Y. Li, <span class="italic">Adv. Mater.</span>, 2018, <span class="bold">30</span>, 1802378 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201802378" title="DOI Link to resource 10.1002/adma.201802378">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29989211%5Buid%5D" title="PubMed Link to resource 29989211">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/17_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit18">D. Wang, H. Dong, M. Li, Y. Cao, F. Yang, K. Zhang, W. Dai, C. Wang and X. Zhang, <span class="italic">ACS Nano</span>, 2018, <span class="bold">12</span>, 5241–5252 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.7b08355" title="DOI Link to resource 10.1021/acsnano.7b08355">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhtVWntrvM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29800517%5Buid%5D" title="PubMed Link to resource 29800517">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/18_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit19">S. Zhang, Q. Huang, L. Zhang, H. Zhang, Y. Han, Q. Sun, Z. Cheng, H. Qin, S. Dou and Z. Li, <span class="italic">Nanoscale</span>, 2018, <span class="bold">10</span>, 3130–3143 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C7NR06937E&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C7NR06937E">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/19_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit20">Y. Jiang, J. Li, X. Zhen, C. Xie and K. Pu, <span class="italic">Adv. Mater.</span>, 2018, <span class="bold">30</span>, 1705980 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201705980" title="DOI Link to resource 10.1002/adma.201705980">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29457284%5Buid%5D" title="PubMed Link to resource 29457284">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/20_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit21">X. Ding, C. H. Liow, M. Zhang, R. Huang, C. Li, H. Shen, M. Liu, Y. Zou, N. Gao and Z. Zhang, <span class="italic">J. Am. Chem. Soc.</span>, 2014, <span class="bold">136</span>, 15684–15693 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja508641z" title="DOI Link to resource 10.1021/ja508641z">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSjsrzL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25340966%5Buid%5D" title="PubMed Link to resource 25340966">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/21_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit22">H. Lin, S. Gao, C. Dai, Y. Chen and J. Shi, <span class="italic">J. Am. Chem. Soc.</span>, 2017, <span class="bold">139</span>, 16235–16247 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.7b07818" title="DOI Link to resource 10.1021/jacs.7b07818">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhslSitrnM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29063760%5Buid%5D" title="PubMed Link to resource 29063760">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/22_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit23">A. Li, X. Li, X. Yu, W. Li, R. Zhao, X. An, D. Cui, X. Chen and W. Li, <span class="italic">Biomaterials</span>, 2017, <span class="bold">112</span>, 164–175 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2016.10.024" title="DOI Link to resource 10.1016/j.biomaterials.2016.10.024">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xhs12nurjJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27768971%5Buid%5D" title="PubMed Link to resource 27768971">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/23_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit24">X. Liu, H. Su, W. Shi, Y. Liu, Y. Sun and D. Ge, <span class="italic">Biomaterials</span>, 2018, <span class="bold">167</span>, 177–190 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2018.03.030" title="DOI Link to resource 10.1016/j.biomaterials.2018.03.030">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXlt1Squr8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29571053%5Buid%5D" title="PubMed Link to resource 29571053">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/24_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit25">W. Liu, M. Ruan, Y. Wang, R. Song, X. Ji, J. Xu, J. Dai and W. Xue, <span class="italic">Small</span>, 2018, <span class="bold">14</span>, 1801754 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/smll.201801754" title="DOI Link to resource 10.1002/smll.201801754">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30141569%5Buid%5D" title="PubMed Link to resource 30141569">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/25_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
      <li><span id="cit26">C. Grabinski, N. Schaeublin, A. Wijaya, H. D’Couto, S. H. Baxamusa, K. Hamad-Schifferli and S. M. Hussain, <span class="italic">ACS Nano</span>, 2011, <span class="bold">5</span>, 2870–2879 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nn103476x" title="DOI Link to resource 10.1021/nn103476x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXjs1Sit7c%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21405102%5Buid%5D" title="PubMed Link to resource 21405102">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50001067/c9cc03148k/26_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50001067"/></a>.</span></li>
    </ol>
    
    
    
    
    
  <hr/><table><tr><td><h3>Footnote</h3></td></tr><tr><td><span class="sup_ref">† <span id="fn1">Electronic supplementary information (ESI) available: Experimental methods and additional data. See DOI: <a href="http://xlink.rsc.org/?DOI=c9cc03148k" target="_blank" title="Select to resolve DOI: 10.1039/c9cc03148k">10.1039/c9cc03148k</a></span></span></td></tr></table><table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry 2019</b></td></tr></table></div></div></div></body><script src="/content/scripts/CrossMarkIE.js"> </script><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>